Biopharmaceutical Drug Design and Development

✍ Scribed by Susanna Wu-Pong (auth.), Susanna Wu-Pong PhD, Yongyut Rojanasakul PhD (eds.)

Publisher: Humana Press
Year: 1999
Tongue: English
Leaves: 438
Category: Library

No coin nor oath required. For personal study only.

✦ Table of Contents

Front Matter....Pages i-xii
An Overview of Biotechnology....Pages 1-19
Basic Elements of Molecular Biology....Pages 21-35
Tools for Molecular Analysis....Pages 37-49
Treatment Options....Pages 51-68
Viral Vectors for Gene Therapy....Pages 69-105
Nonviral Gene Delivery....Pages 107-142
Oligonucleotides and Ribozymes....Pages 143-185
Design and Engineering of Proteins as Therapeutic Agents....Pages 187-203
Challenges and Issues in the Development of Formulations of Protein Pharmaceuticals....Pages 205-238
Protein Drug Delivery....Pages 239-273
Protein Drug Manufacturing....Pages 275-327
Antibodies....Pages 329-348
Immunotherapy....Pages 349-373
Product Development and New Drug Approval....Pages 375-392
Therapeutic Use of Recombinant Proteins....Pages 393-427
Back Matter....Pages 429-436

✦ Subjects

Pharmacology/Toxicology; Molecular Medicine; Pharmacy

📜 SIMILAR VOLUMES

Biopharmaceutical Drug Design and Develo

📁 Biopharmaceutical Drug Design and Development

✍ Susanna Wu-Pong (auth.), Susanna Wu-Pong PhD, Yon Rojanasakul PhD (eds.) 📂 Library 📅 2008 🏛 Humana Press 🌐 English

Biopharmaceutical Drug Design and Development, Second Edition, updates the widely successful first edition, published in 1999. This new, expanded edition investigates the dozens of new biopharmaceutical drugs that have become available since the publication of the first edition. Among the drug

Biopharmaceutical Drug Design and Develo

📁 Biopharmaceutical Drug Design and Development Second Edition

✍ Susanna Wu-Pong, Yon Rojanasakul 📂 Library 📅 2008 🏛 Humana Press 🌐 English

This book provides a comprehensive examination of the newest biopharmaceutical drugs. Among the drugs discussed are ones in the categories of monoclonal antibodies for in-vivo use, cytokines, growth factors, enzymes, immunomodulators, thrombolytics, and immonotherapies including vaccines. Additional

Quality by Design for Biopharmaceutical

📁 Quality by Design for Biopharmaceutical Drug Product Development

✍ Feroz Jameel, Susan Hershenson, Mansoor A. Khan, Sheryl Martin-Moe (eds.) 📂 Library 📅 2015 🏛 Springer-Verlag New York 🌐 English

This volume explores the application of Quality by Design (QbD) to biopharmaceutical drug product development. Twenty-eight comprehensive chapters cover dosage forms, liquid and lyophilized drug products. The introductory chapters of this book define key elements of QbD and examine how these e

Modern Biopharmaceuticals: Design, Devel

📁 Modern Biopharmaceuticals: Design, Development and Optimization

📂 Library 📅 2005 🏛 Wiley-Blackwell 🌐 English

The biopharmaceutical market has come along way since 1982 when the first biopharmaceutical product, recombinant human insulin, was launched. Over 120 such products are currently being marketed around the world including nine blockbuster drugs. The global market for biopharmaceuticals, which is

Biopharmaceutics applications in drug de

📁 Biopharmaceutics applications in drug development

✍ Rajesh Krishna, Lawrence Yu 📂 Library 📅 2008 🏛 Springer 🌐 English

In the last two decades, the discipline of biopharmaceutics has undergone considerable advances, particularly with regard to bioavailability and bioequivalence as they relate to product quality and regulatory standards of approval. Textbooks in the field have not been able to keep up with the growth

Biopharmaceutics Applications in Drug De

📁 Biopharmaceutics Applications in Drug Development

✍ Rajesh Krishna, Lawrence Yu 📂 Library 📅 2007 🏛 Springer 🌐 English